BUY Aarti Drugs Limited — Axis Securities
byAxis SecuritiesHorizon: NA (inferred 1 year)11 Oct 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·9 Oct · 3d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aarti Drugs
- BUY — Somil Mehta, Sharekhan24 Sept 2026 · ~2 weeks · target ₹550 · Expired
- BUY — Siddharth Rai Mangala1 Sept 2026 · ~2 weeks · target ₹445 · Expired
- BUY — Sahi Research24 Aug 2026 · ~2 weeks · target ₹438 · SL hit
- BUY — Axis Securities19 Aug 2026 · ~1 year · target ₹515 · Active
- BUY — Axis Securities5 Feb 2026 · ~1 year · target ₹480 · Active
More from Axis Securities
- BUY Tata Consultancy Services8 Oct 2026 · ~3 months · target ₹2,360 · Active
- BUY HDFC Bank5 Oct 2026 · ~1 year · target ₹785 · Active
- BUY Skipper3 Oct 2026 · ~1 year · target ₹595 · Active
- BUY Ethos1 Oct 2026 · ~1 year · target ₹3,360 · Active
- BUY Galaxy Surfactants1 Oct 2026 · ~3 months · target ₹2,750 · Active

